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Background: Chronic neuropathic pain has a major effect on quality of life. In order to 
prevent neuropathic pain from becoming chronic and improve neuropathic pain care, it is 
important to identify predictors associated with the persistence of neuropathic pain.
Objective: To identify potential predictors associated with the persistence of neuropathic 
pain.
Study Design: A 2-round Delphi study.
Setting: University Medical Center and Pain Management Research Center
Methods: A 2-round Delphi study was conducted among 17 experts in the field of 
neuropathic pain. Selection of the panel was based on the citation index ranking for 
neuropathic pain-related research and/or membership in the neuropathic pain special 
interest group of the International Association for the Study of Pain (IASP), complemented 
with experts with demonstrated field knowledge.
Potential predictors were categorized according to the International Classification of 
Functioning, Disability and Health model. Participants were asked to identify important 
predictors, suggest new predictors, and grade the importance on a 0-10 scale. For the 
second round, predictors were considered important if the median score was ≥ 7 and the 
interquartile range (IQR) ≤ 3.
Results: In the first round, 20 predictors were selected and 58 were added by the 
experts (patient characteristics [15], environmental factors [25], functions & structure [4], 
participation & health related quality of life [14]). In the second round, 12 predictors were 
considered important (patient characteristics [4; e.g., depression, pain catastrophizing], 
environmental factors [surgery as treatment for neuropathic pain], functions & structure 
[6; e.g., allodynia, duration of the complaints], participation & trait anxiety/depression as a 
part of health related quality of life). Presence of depression and pain catastrophizing were 
considered the most important predictors for chronic neuropathic pain (median ≥ 8;IQR ≤ 2).
Limitations: The study design did not include plenary discussion among the experts. The 
meaning of the individual topics used in this study could have been subject to interpretation bias. 
Conclusions: Overall, psychological factors and factors related to sensory disturbances 
were considered important predictors for persistence of neuropathic pain. Activity related 
factors and previously received paramedical and alternative treatment were considered to be 
less important. The list of possible predictors obtained by this study may serve as a basis for 
development of a clinical prediction rule for chronic neuropathic pain.
Key words: Neuropathic pain, chronic pain, persistence, Delphi study, opinion, predictors, 
ICF model.
Pain Physician 2011; 14:559-568
Clinical Study
Predictors for Persistent Neuropathic Pain 
– A Delphi Survey
From: 1Department of Anesthesiology, 
VU University Medical Center, 
Amsterdam; 2Trauma Related 
Neuronal Dysfunction (TREND), Delft; 
3EMGO+ Institute for Health and Care 
Research, Amsterdam; 4Department 
of Epidemiology and Biostatistics, VU 
University Medical Center, Amsterdam; 
5Pain Management and Research Center 
(PKC), Maastricht; 6Department of 
Anesthesiology, Maastricht University 
Medical Center, Maastricht; 7Maastricht 
Department of Neurology, Maastricht 
University Medical Center, Maastricht; 
8Department of Clinical Psychological 
Science, Maastricht University, 
Maastricht
Address correspondence:
S. Boogaard, MSc
VU University Medical Center
Department of Anesthesiology
PO Box 7057
1007 MB Amsterdam
The Netherlands
E-mail: s.boogaard@vumc.nl 
Disclaimer: The study was performed 
within TREND (Trauma RELated 
Neuronal Dysfunction), a consortium 
that integrates research on 
epidemiology, assessment technology, 
pharmacotherapeutics, biomarkers 
and genetics on complex regional pain 
syndrome. TREND is supported by a 
Dutch Government grant (BSIK03016). 
This study was funded by an 
unrestricted grant from DALI for PAIN 
(Dutch Alliance for Improvement of pain 
care), a national program sponsored by 
Pfizer that focuses on neuropathic pain 
care optimalization. 
Conflict of interest: None.
Manuscript received: 08/25/2011 
Revised manuscript received: 09/25/2011
Accepted for publication: 10/03/2011 
Free full manuscript:
www.painphysicianjournal.com
Sabine Boogaard, MSc1,2, Martijn W. Heymans, PhD3,4, Jacob Patijn, MD, PhD5,6, 
Henrica CW de Vet, MD, PhD3,4, Catharina G. Faber, MD, PhD7, Madelon L. Peters, PhD8, 
Stephan A. Loer, MD, PhD1, Wouter WA Zuurmond, MD, PhD1,2, and Roberto SGM Perez, PhD1-3
www.painphysicianjournal.com
Pain Physician 2011; 14:559-568 • ISSN 1533-3159
Pain Physician: November/December 2011; 14:559-568
560  www.painphysicianjournal.com
face-to-face (24), so it is relatively simple to assemble 
a group of experts from all over the world (29). 
Therefore, by means of a Delphi survey, we sought 
to identify potential predictors associated with persis-
tent NP.
Methods
A 2-round Delphi survey  was conducted among 
experts in the field of neuropathic pain. The expert 
panel composition was based on ranking in the cita-
tion index for neuropathic pain-related research and/
or membership of the working group NEUropathic Pain 
Special Interest Group (NEUPSIG) of the International 
Association for the Study of Pain (IASP). The selected 
experts were required to work in a discipline involved 
in treating neuropathic pain patients and/or have a 
wide extent of research or clinical expertise in the field. 
Furthermore, experts with demonstrable specific field 
knowledge and coordinators of Dutch pain clinics were 
invited to participate in the panel of experts. Since the 
outcome of this study was intended to be used for the 
development of a prediction rule for a clinical setting, 
we aimed to include a majority of experts with clinical 
expertise.
Using e-mail and regular mail, experts were invited 
to participate in the study. Selected experts received 
information about the study’s goal, the study’s impor-
tance, the study’s procedure and expected time cost; 
these were accompanied by a request for participation. 
Three weeks after sending the original invitation,  ex-
perts who did not respond received a reminder letter 
and e-mail. Experts who agreed to participate received 
their first questionnaire within 4 weeks.
The first questionnaire contained a list of possible 
predictors which were categorized according to the 
World Health Organization International Classification 
of Functioning, Disability and Health (ICF) model, i.e., 
personal factors; environmental factors; functions & 
structure; activities; and participation and HRQoL (27). 
Predictors were included on the basis of a literature 
search and subsequent discussion by our project team. 
In the first round’s questionnaire, experts were 
asked to point out factors which they believed to be 
possible predictors for persistent neuropathic pain. The 
given answering options were yes, no, or no opinion. 
The questionnaire consisted of 50 items: 13 items for 
each of the domains personal factors and environ-
mental factors; 21 items for the domain functions & 
structure, including symptoms (13 items) and factors of 
dysregulation (8 items); one item for the domain activi-
Neuropathic pain (NP) arises as a consequence of activity generated within the nociceptive system without adequate stimulation of its 
peripheral sensory endings (1). It appears to be more 
common than initially expected, is associated with more 
intense pain than other forms of pain, and considerably 
impairs patients’ quality of life (2-7). Currently, 
approximately 6-8% of the general population 
reports chronic pain with a neuropathic component 
(8). Furthermore, due to the aging population, it is 
assumed that the prevalence of chronic neuropathic 
pain (CNP) will increase in the future. Therefore, the 
health care system should provide more efficient care 
to cope with an increased quantity of patients (5). A 
variety of factors has been suggested to be associated 
with the development of CNP.
Knowledge about predictors for CNP may lead 
to timely identification of patients with a possible 
adverse disease course, and prompt preventive mea-
sures or result in more intensive treatment for pa-
tients at risk. Therefore, in order to improve NP care, 
it is important to identify possible predictors for CNP. 
From the literature it is known that age (9-17), sex 
(11,13,18), pain catastrophizing (19), numbness (20), 
different measures of pain intensity (14,21) — such as 
the predictive value of the Visual Analog Scale (VAS) 
> 5 at baseline for postherpetic neuralgia (PHN) at 3 
and 6 months (10), and a Leeds Assessment of Neu-
ropathic Symptoms and Signs (LANSS) score ≥ 12 in 
the postoperative period as a predictor for CNP af-
ter 3 months (22) — and prodromal symptoms and 
intensity of the rash (9,12) have been identified as 
predictors for NP or CNP. Women (12) and impaired 
Health-Related Quality of Life (HRQoL) (3) have been 
described as negative effect-modifying factors. Con-
trarily, severe depressive symptomatology (23) was 
reported as a positive effect-modifying factor. None-
theless, the amount of research performed into iden-
tifying predictive factors for NP or the persistence of 
NP remains limited. However, unpublished scientific 
knowledge and knowledge gathered in a practical 
setting may be available, and clinicians and other ex-
perts involved in the treatment of neuropathic pain 
may have an idea about prognostic factors from their 
clinical experience. This information can be acquired 
using a Delphi survey technique. This is a method for 
the systematic collation of judgments, through which 
agreement can be achieved in a given area of un-
certainty when empirical evidence is lacking (24,25). 
Participants in a Delphi survey do not have to meet 
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ties; and 2 items for participation and HRQoL (Table 1). 
Experts were invited to add variables and make com-
ments on the provided list of variables. A reminder was 
sent to experts not responding within one month. As an 
arbitrary criterion for expert agreement, variables were 
selected which at least 75% of the experts indicated to 
be a potential predictor for CNP. These variables were 
included in the second round. 
In the second round questionnaire, participants 
were asked to grade the importance of  the remaining 
potential predictors of the first questionnaire, along 
with the items added by the experts, on a Numeric Rat-
ing Scale (NRS) (0 = absolutely no possible predictor; 
10 = very important possible predictor). Once again, 
experts were provided with the opportunity to make 
comments on the list of variables. Also in this round, 
a reminder was sent to experts who did not respond 
within the given time range.
In both questionnaires, experts had the opportu-
nity to refrain from answering if they had insufficient 
knowledge about a specific item. Only data in which an 
actual judgment was given were included in the analy-
sis. Therefore, percentages were determined with exclu-
sion of the option “no opinion.”
The data were processed using MS Excel 2003 (Mi-
crosoft Corporation, Redmond, WA). Statistical analy-
ses were performed using the SPSS 15.0 statistical soft-
ware package (SPSS Inc., Armonk, NY). For selecting 
the most important predictors for persistent NP, we 
defined an interquartile range (IQR) classification of ≤ 
3 as an indicator for expert agreement. Together with 
the IQR, we arbitrarily defined the optimal cutoff value 
at a median of 7, based on procedures followed in a 
comparable Delphi survey (28). 
Results
Out of 43 experts invited, 21 (50%) agreed to par-
ticipate in the project and returned the first question-
naire. These experts came from the Netherlands (7), 
the United States of America (7), Germany (3), France 
(2), Italy (1) and Australia (1). Nine experts declined: 5 
because of workload, 3 because of insufficient clinical 
experience, and one because of retirement. Thirteen 
experts did not respond to our request. Participating 
experts were professors or PhDs working in the fields 
of neurology, anesthesiology, pain research, medical 
psychology and behavioral science, and a nurse practi-
tioner working in the field of pain. 
Table 1. Items included in the first questionnaire.
Personal Patient Factors Environmental Patient Factors Functions and Structure
General patient characteristics
    Age
    Gender
    Education
    Work status
Absence or presence of:
    Depression
    Trait anxiety
    Pain coping
    Pain catastrophizing
    Fear of movement
Physical comorbidity
Patient Global Impression of Chance
Patient Global Impression of Efficacy
Patient Global Expectancy of Prognosis
Social support
Complaint related variables:
    Underlying cause
Treatment for neuropathic pain:
    Drug use
    Invasive pain treatment
    Surgery
    Paramedical treatment
    Alternative treatment
Treatment other than for neuropathic pain:
    Drug use
    Invasive pain treatment
    Surgery
    Paramedical treatment
    Alternative treatment
Duration of the complaints
Absence or presence of:
    (Spontaneous) pain
    Allodynia – general 
    Allodynia – tactile 
    Allodynia – deep pressure
    Allodynia – movement
    Hyperesthesia
    Hypoesthesia
    Hyperalgesia
    Hypoalgesia
    Dysesthesia
    Paresthesia
    Hyperpathia
    Summation / wind-up
Dysregulation of:
The autonomic nervous system
    Heart rate variability (HRV)
The sensory nervous system
     Decreased diffuse noxious inhibitory control 
(DNIC)
The endocrine system
     Abnormal sleep/wake rhythm and/or sleeping 
problems
The immune system
    Th1/Th2 ratio
Activities
Activities
Participation & HRQoL 
Participation
Health Related Quality of Life
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In the first round, 20 predictors, representing all 
categories of the model, were considered to be possible 
predictors for persistent neuropathic pain (Table 2).  
For patient characteristics, factors selected by at 
least 75% of the experts were primarily of a psychologi-
cal nature, such as the absence or presence of depres-
sion (100%), trait anxiety (100%), pain coping (78%), 
pain catastrophizing (91%) and fear of movement 
(79%). Also, age (86%) and Patient Global Expectancy 
of Prognosis (90%) were frequently chosen by the ex-
perts. General patient characteristics were selected 
less often, such as gender (55%), education (38%) and 
work status (60%). Within the environmental factors 
category, 2 factors were classified as potential predic-
tors for persistence of NP: underlying cause of the com-
plaints (81%) and surgery as treatment for neuropathic 
pain (75%). For both subcategories containing specific 
treatment for NP and treatment in general, the low-
est prognostic influence was expected for paramedical 
treatment (respectively 21% and 7%) and for comple-
mentary medicine (respectively 17% and 8%). Regard-
ing the category symptoms of NP within the functions 
and structure domain, allodynia (82%), tactile allodynia 
(82%), and hyperpathia (80%) were considered to be 
Table 2. Possible predictors after the 1st round.
Main Category Variable ≥75%
Personal patient factors
Age 85.7
Absence or presence of depression 100
Absence or presence of trait anxiety 100
Absence or presence of pain coping 77.8
Absence or presence of pain catastrophizing 90.5
Absence or presence of fear of movement 79
Patient Global Expectancy of Prognosis  90
Environmental factors
Underlying cause of the complaints 81
Surgery as treatment for Neuropathic Pain 75
Functions and structure
Duration of the complaints 90
Symptoms
Allodynia – general 82.4
Allodynia – tactile 82.4
Hyperpathia 80
Factors of dysregulation
The sensory nervous system 88.9
Decreased Diffuse Noxious Inhibitory Control (DNIC) 93.8
The endocrine system 78.6
Abnormal sleep/wake rhythm and/or sleeping problems 88.2
Activities
Activities 88.9
Participation and HRQoL
Participation 89.5
Health Related Quality of Life 100
www.painphysicianjournal.com  563
Prediction of Neuropathic Pain
possible predictors. For other symptoms, such as hy-
peresthesia (60%), hypoalgesia (37%), and paresthesia 
(40%), experts expected low predictive influence. There 
was expert agreement for sensory nervous system dys-
regulation (89%), including the suggested test for de-
creased diffuse noxious inhibitory control (DNIC) (94%), 
and for endocrine system dysregulation (79%), includ-
ing assessment of abnormal sleep/wake rhythm and/
or sleeping problems (88%). For immune system dys-
regulation (64%) and dysregulation of the autonomic 
system (56%), expert agreement was insufficient for 
inclusion in the second Delphi round. The item dura-
tion of the complaints was also frequently selected by 
the experts (90%). The factor activities were considered 
to be a possible predictive factor with a score of 89%. 
Finally, experts agreed about variables for participation 
(90%) and HRQoL (100%). 
Fifty-eight predictors, distributed over 4 catego-
ries—patient characteristics (15), environmental fac-
tors (25), functions & structure (4) and participation 
and HRQoL (14) —were added by the experts (Table 3). 
Within the latter topic, the addition of variables was a 
consequence of subdividing HRQoL into 13 constituting 
components, as suggested by one of the experts. 
All variables with an expert agreement of at least 
75% (20) were included in the second round, complet-
ed with the items added by the experts (58). This second 
questionnaire was returned by 17 experts, which means 
4 experts (19%) dropped out between the first and the 
second round. Based on the previous defined median 
cut-off value of 7, together with an IQR ≤ 3, 12 items 
were identified as important predictors for persistent 
neuropathic pain (Table 4). Nine of these items were 
previously identified as possible predictors in the first 
round (absence or presence of depression, trait anxiety, 
pain coping and catastrophizing, duration of the com-
plaints, surgery as treatment for NP, allodynia, tactile 
allodynia, and hyperpathia). Three added factors—con-
tinued high pain and duration of continuing pain, trait 
anxiety/depression as part of HRQoL—were also graded 
as important predictive factors.  
Compared to the first round, the personal factors 
age (median 6, IQR 4), fear of movement (median 6, IQR 
3) and Patient Global Expectancy of Prognosis (median 
6, IQR 2.5) were not considered important predictors, 
as was the underlying cause of the complaints (median 
7, IQR 3.5) in the domain environmental factors. With 
regard to factors of dysregulation, neither the sensory 
nervous system (median 6, IQR 2.5) or the endocrine 
system (median 5.5, IQR 1.5), nor their suggested as-
sessment techniques (DNIC [median 6, IQR 3]) and ab-
normal sleep/wake rhythm and/or sleeping problems 
(median 6, IQR 1), were considered to be important 
predictors in the second round. Finally, activities (me-
dian 6, IQR 2) and participation (median 6, IQR 2) were 
considered less important. 
Based on these expert findings, the strongest pre-
dictors for persistence of neuropathic pain were the 
presence of depression and pain catastrophizing (me-
dian ≥ 8, IQR ≤ 2). 
discussion
In our Delphi study, psychological factors and fac-
tors related to sensory disturbances were recognized by 
the experts as important predictors of persistent neu-
ropathic pain. The most important predictors were the 
absence or presence of depression and pain catastroph-
izing. To our knowledge, a Delphi study has not been 
performed for this purpose before.
The predictors that emerged from this study were 
distributed over most of the domains covered by the 
International Classification of Functioning, Disability 
and Health model (27). In the literature, several of the 
predictors identified in our study have been named as 
predictors for the development of neuropathic pain. 
Specifically, pain coping was reported to be predic-
tive for developing phantom limb pain (29,30), forms 
of allodynia, and postherpetic neuralgia (PHN) (31,32). 
In addition, other predictors found in our study were 
reported previously in the literature as specific predic-
tors for persistent NP. In this context, pain catastroph-
izing was reported as a predictor for chronic PHN (19), 
and depression and trait anxiety were both found to 
be predictors for chronic herpes zoster pain (33). Also, 
depressive symptomatology was considered to be a 
negative effect-modifier in people with chronic NP af-
ter spinal cord injury (23). Continued high pain intensity 
was found to be a predictor for chronic herpes zoster 
pain (33). The latter also proved to be the case for PHN 
patients (10,34,35). A similar correlation between previ-
ously experienced pain and CNP for neuropathic pain 
disorders in general has been described (13). 
Several predictors were identified in this study that 
were not described previously in the context of devel-
opment of chronic neuropathic pain. For chronic pain in 
general, however, most of these predictors have been 
reported to be predictive for its development. This was 
the case for trait anxiety/depression as a part of HRQoL 
(36), previous duration of continuing pain (37), and sur-
gery for neuropathic pain (37-39). Only hyperpathia, a 
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Table 3. List of  predictors added by the experts after the 1st round.
Personal Patient Factors
General patient characteristics: Religion 
Satisfaction with work 
Motivation for continuing work 
Family factors (congenital) 
Unresolved grief 
Anger at circumstances that caused the pain 
Anger at circumstances instigated by the pain
Physical comorbidity: Presence of another pain inflicting condition 
Other physical comorbidity 
Mental comorbidity: Post-traumatic stress disorder
Obsessive compulsive disorder
Other mental comorbidity
Cognitions Cognitions of the disease
Cognitions of treatment
Other cognitive variables
Environmental Patient Factors
Family situation 
Family history (i.e., parent with chronic pain) History of childhood abuse 
Compensation claims / disability payments
Complaint-related variables: First causality of the pain 
Time duration between pain onset and therapy start 
Number of successful treatments 
Number of unsuccessful treatments 
Traumatic cause of the pain 
Treatment for neuropathic pain: Effect of treatment 
Medication: Dosage and duration of drug use  
Medication: Effect of medication 
Invasive pain treatment
In case of surgery: Applied technique 
In case of surgery: Quality of post-operative analgesia 
In case of surgery: Maximal pain score on VAS-scale 
In case of surgery: Opioid-induced hyperalgesia 
Treatment other than for neuropathic pain: Effect of treatment 
Medication: Dosage and duration of drug use  
Medication: Effect of medication 
Invasive pain treatment 
In case of surgery: Applied technique 
In case of surgery: Quality of post-operative analgesia 
In case of surgery: Maximal pain score on VAS-scale 
In case of surgery: Opioid-induced hyperalgesia
Functions and Structure
History of the pain
Duration of continuing pain
Continued high pain 
Extent of the injury
Activities None
Participation and HRQoL
Health-Related Quality of Life              Bodily pain                                    
Daily activities                                
Self care                                          
Physical functioning                                    
Social functioning                               
Mobility                                                
Vitality                                        
Experienced health                                      
Disabilities caused by physical health problems         
Disabilities caused by emotional problems               
Trait anxiety/depression
Cognition (memory, concentration)           
Mental health              
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painful syndrome characterized by a painful reaction to 
a repetitive stimulus (40), has not been described in the 
context of developing either NP or chronic pain. 
In addition, the literature provides support for vari-
ables which were not among the most important predic-
tors of CNP identified in our study: hypoesthesia (31,35), 
hyperalgesia (36), age (9,10,13-15,34,39), prodromal 
symptoms (9), numbness (20), different measures of pain 
intensity such as LANSS (22) or NRS (21), severity of coe-
taneous manifestation (35) and DNIC (42).
These discrepancies between our results and the lit-
erature findings may be related to the focus of previous 
reported research on single diseases or specific patient 
groups. Furthermore, some articles were not specifically 
aimed at identifying predictors. 
We used the ICF model as a conceptual framework 
to find possible predictors for CNP. We started with fac-
tors which represented all domains of the model, in 
order to depart from a comprehensive perspective of 
disease development. 
However, some domains of the ICF model were 
considered less important, such as activities, participa-
tion, HRQoL, and factors of dysregulation. This agrees 
with current literature, where the amount of informa-
tion regarding these domains of the ICF model is gener-
ally limited.  
The literature provides only a few studies underlin-
ing the predictive value of daily activities for a nega-
tive disease outcome in neuropathic pain syndromes 
(34,43). Likewise, only recently a study showed that par-
ticipation expressed as relations with other people and 
working ability (indirectly modulated by experienced 
pain) was predictive for the development of PHN (34). 
One possible explanation for the fact that activities and 
participation are only anecdotally described in the con-
text of health status prediction might be that both are 
normally seen as outcomes of a disease rather than as 
predictors for disease progression. 
One exception was found in the importance the 
experts ascribed to trait anxiety/depression as a part 
of HRQoL. The fact that this HRQoL domain stands out 
may possibly be related to the fact that both trait anxi-
ety and depression were considered important predic-
tors as personal factors in a general sense in this study. 
Whether developing chronic neuropathic pain and 
general trait characteristics of anxiety and depression 
are predictive, or are only predictive in the context of 
HRQoL, remains to be determined. 
All aspects considered, research appears to be re-
quired to establish the role of activities, participation, 
and quality of life as predictors for the disease course of 
CNP or chronic pain in general.
The findings of our study indirectly relate to patho-
physiological perspectives underlying the development 
of chronic pain. Applying a systems approach, dysregu-
lation of interlinked subsystems, in particular the cen-
tral nervous system, the endocrine system and immune 
system, have been postulated as a reason for pain to 
become chronic (44). Consequently, prolonged dysregu-
lation in one of the subsystems might lead to chronic 
pain, whereby different pathophysiological mechanisms 
were suggested as markers for these dysregulations (45) 
(i.e., decreased heart rate variability and HPA axis distur-
bances for  autonomic dysregulation, decreased DNIC for 
sensory nervous system dysregulation, sleep disturbanc-
es as a marker of endocrine system dysregulation, and 
skewed Th1/Th2 ratio for immune system dysregulation). 
Although the system dysregulations proposed as pre-
dictors in our study were not directly considered to be 
important predictors, individual factors associated with 
these dysregulations (i.e., depression, pain catastrophiz-
ing and anxiety for the HPA axis dysbalance, allodynia 
and hyperpathia for sensory nervous system dysregula-
tion) were identified as important predictors.
One of the advantages of a Delphi survey is the 
possibility to disclose expert knowledge that is not cap-
Table 4. Important predictors after the 2nd round.
Predictive Factors Median
IQR 
(25-75)
Personal patient factors
Absence or presence of:
    Depression                                              8 8-6
    Trait anxiety                                           7 8-6
    Pain coping                                             7 8-5.5
    Pain catastrophizing                                         8 8.5-6.5
Environmental factors
Surgery as treatment for neuropathic pain             7 8-5
Structure and functions
Duration of the complaints                              7 8-5.5
Duration of continuing pain                            7 8-5.5
Continued high pain                                     7 8-7
Allodynia – general                                                7 8-5
Allodynia – tactile                                     7 8-5.5
Hyperpathia                                             7 8-5.5
Participation and HRQoL
Trait anxiety/depression as part of HRQoL 7 8-6
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tured in the scientific literature. Furthermore, different 
viewpoints, depending upon the specific background 
of the expert, can be incorporated in the generation 
of information. In our study, 58 items were added by 
the experts, of which 2 were considered as important 
predictors in the final analysis. Another strength of the 
procedure followed in the present study is the flex-
ibility that allowed experts to respond at their conve-
nience, without the requirement of travel time (24). 
The Delphi procedure followed in our study requires 
high participant motivation, since other people are not 
present to stimulate individual contributions (24). The 
limited dropout rate between rounds in our study may 
be an expression of the value placed by the contribu-
tors on the identification of predictors for the disease 
course of NP. In addition, by inviting experts from dif-
ferent disciplines and continents, the generalizability of 
the outcome might be increased. 
However, some limitations have to be taken into 
account regarding the method of our investigation. 
The procedure followed in our study did not allow for 
plenary discussion of the value of individual predictors. 
Possibly, another model with a different set of predic-
tors could have emerged as a consequence of the dis-
cussion dynamics. On the other hand, our approach 
allowed the experts to express opinions in relative ano-
nymity. A point of discussion is the number of consulta-
tion rounds that have been used in this study. In order 
to limit the amount of burden for the experts, a 2 round 
approach, which has been used successfully in previous 
Delphi procedures, was chosen (28,45). However, other 
Delphi approaches could have been chosen allowing 
more than 2 consultation rounds (24), which could have 
led to different outcomes than found in our study.
Another point of discussion is the possible differ-
ence in interpretation of the proposed predictors. Since 
we provided no additional definition regarding the 
topics, their meaning could have been subject to inter-
pretation bias. A possible example of this can be found 
in the difference in acceptance of “paramedical treat-
ment” as a potential predictor for CNP. Dutch experts 
responded positively on this (where physiotherapy and 
occupational therapy are referred to as paramedical 
treatment), whereas none of the other experts chose 
this option (possibly interpreting this as referring to 
emergency care). This might also be the case for the 
rather broad term “activities.” 
Furthermore, the multidisciplinary background of 
the experts can also introduce a bias in the direction 
of the clinical or scientific orientation of the experts 
in question. For instance, respondents with specific (or 
exclusive) expertise in the field of postherpetic neu-
ralgia, may choose the predictors related to this spe-
cific disease, and these may differ from those in other 
neuropathic pains. Although the statistical consensus 
approach used in our study by combining different 
disciplinary perspectives most probably reduced this 
directional bias, we cannot rule out a possible influ-
ence of this kind. In line with this issue, our approach 
to identify predictors for persistent neuropathic pain 
in general did not allow for the identification of dis-
ease specific predictors. The clinical value of the pre-
dictors identified in this study, and the possible disease 
specificity of certain predictors, therefore remain to 
be determined. Whether or not the predictive value 
of the factors hold true in a clinical setting can only 
be established in a prospective cohort study following 
the disease course of acute neuropathic pain patients 
with a sufficient follow-up period. 
 How the term “chronic” neuropathic pain is de-
fined needs to be addressed. From a mechanistic per-
spective, the requirements for persistent complaints 
of NP may be present from the start, and as such NP 
by definition should be considered a form of chronic 
pain. However, in the scope of our study we used the 
term chronic in a temporal sense, that is, persistent 
neuropathic pain, in order to distinguish between 
those cases where neuropathic pain is resolved before 
the time frame usually considered as a cut off point for 
chronic pain (i.e., 3-6 months or more) and those that 
do proceed into the chronic phase. We acknowledge, 
however, that the definition of chronic pain in general 
remains an ongoing discussion, and consensus in this 
regard remains to be established.  
Taking all considerations into account, we con-
clude that the list of possible predictors obtained by 
this study may serve as a basis for the development of 
a prediction rule for CNP, which will help identify pa-
tients at risk for persistent pain, and enable tailor-made 
interventions for NP patients, thereby reducing patient 
and societal burdens associated with NP. 
Overall, psychological factors and factors related 
to sensory disturbances are considered to be important 
possible predictors for CNP, with the presence of de-
pression and pain catastrophizing indicated as the most 
important predictors.
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